Evercore ISI analyst Vijay Kumar raised the firm’s price target on Intuitive Surgical to $475 from $410 and keeps an In Line rating on the shares. In MedTech, utilization remains positive into Q3 and the capex outlook into the next year remains “healthy,” says Evercore. In life science tools, bioprocess trends for are on track for improvement in the second half, but the debate is around the instrument outlook and China stimulus given the recent run in stocks in the space, the analyst tells investors in MedTech and Tools Q3 preview.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical put volume heavy and directionally bearish
- Intuitive Surgical price target raised to $494 from $469 at BTIG
- Intuitive Surgical price target raised to $560 from $512 at Citi
- Intuitive Surgical price target raised to $515 from $475 at RBC Capital
- Intuitive Surgical upgraded to Buy from Neutral at Redburn Atlantic